Question 1

What is Atai Life Sciences?

Accepted Answer

Atai Life Sciences is a Person.

Question 2

How often does Atai Life Sciences appear in global news?

Accepted Answer

Tracked across 2 news events drawn from 36 articles.

Question 3

When was Atai Life Sciences first tracked by Ergen?

Accepted Answer

First tracked on Apr 18, 2026.

Question 4

When was Atai Life Sciences last mentioned in news?

Accepted Answer

Last active on May 17, 2026.

Question 5

What is Atai Life Sciences's current news sentiment?

Accepted Answer

Aggregate sentiment score: 25 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Atai Life Sciences in global news coverage?

Accepted Answer

Attention score of 6, derived from article volume and coverage intensity across 2 events.

Question 7

What is the most recent event involving Atai Life Sciences?

Accepted Answer

AtaiBeckley Wins Silver Patient Award (Apr 27, 2026, 7 articles).

Question 8

How did the "AtaiBeckley Wins Silver Patient Award" event impact Atai Life Sciences?

Accepted Answer

Atai Life Sciences received a Silver Award in Ovid Health's 2026 Patient Participant Index for its collaboration with Psychedelic Participant Advocacy Network, enhancing its reputation in patient-informed research and potentially boosting investor confidence.

Question 9

How did the "Trump Accelerates Psychedelic Drug Reviews" event impact Atai Life Sciences?

Accepted Answer

Atai Life Sciences is a company studying MDMA and other psychedelic compounds, benefiting from investments from figures like Peter Thiel as the regulatory environment shifts.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.